Journal Article DZNE-2022-00263

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2022
IOS Press Amsterdam

Journal of Alzheimer's disease 85(3), 1267 - 1282 () [10.3233/JAD-215196]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Inflammation has been described as a key pathogenic event in Alzheimer's disease (AD), downstream of amyloid and tau pathology. Preclinical and clinical data suggest that the cholinergic basal forebrain may moderate inflammatory response to different pathologies.To study the association of cholinergic basal forebrain volume and functional connectivity with measures of neuroinflammation in people from the AD spectrum.We studied 261 cases from the DELCODE cohort, including people with subjective cognitive decline, mild cognitive impairment, AD dementia, first degree relatives, and healthy controls. Using Bayesian ANCOVA, we tested associations of MRI indices of cholinergic basal forebrain volume and functional connectivity with cerebrospinal fluid (CSF) levels of sTREM2 as a marker of microglia activation, and serum levels of complement C3. Using Bayesian elastic net regression, we determined associations between basal forebrain measures and a large inflammation marker panel from CSF and serum.We found anecdotal to moderate evidence in favor of the absence of an effect of basal forebrain volume and functional connectivity on CSF sTREM2 and serum C3 levels both in Aβ42/ptau-positive and negative cases. Bayesian elastic net regression identified several CSF and serum markers of inflammation that were associated with basal forebrain volume and functional connectivity. The effect sizes were moderate to small.Our data-driven analyses generate the hypothesis that cholinergic basal forebrain may be involved in the neuroinflammation response to Aβ42 and phospho-tau pathology in people from the AD spectrum. This hypothesis needs to be tested in independent samples.

Keyword(s): Aged (MeSH) ; Alzheimer Disease: pathology (MeSH) ; Basal Forebrain: pathology (MeSH) ; Biomarkers: blood (MeSH) ; Biomarkers: cerebrospinal fluid (MeSH) ; Cholinergic Agents (MeSH) ; Cognitive Dysfunction: pathology (MeSH) ; Cohort Studies (MeSH) ; Female (MeSH) ; Humans (MeSH) ; Inflammation: pathology (MeSH) ; Magnetic Resonance Imaging (MeSH) ; Male (MeSH) ; Alzheimer’s disease ; MRI ; cerebrospinal fluid ; cholinergic system ; neuroinflammation ; plasma ; sTREM2 ; Biomarkers ; Cholinergic Agents

Classification:

Contributing Institute(s):
  1. Clinical Dementia Research (Rostock /Greifswald) (AG Teipel)
  2. Neuropsychology (AG Wagner)
  3. Interventional Trials and Biomarkers in Neurodegenerative Diseases (Biomarker)
  4. Linking imaging projects iNET (AG Speck)
  5. Molecular Neurobiology (AG Simons)
  6. Patient Studies Bonn (Patient Studies Bonn)
  7. Core ICRU (Core ICRU)
  8. Magdeburg common (Magdeburg common)
  9. Parkinson Genetics (AG Gasser)
  10. Interdisciplinary Dementia Research (AG Endres)
  11. Translational Neuropsychiatry (AG Priller)
  12. Clinical Research Platform (CRP) (Clinical Research Platform (CRP))
  13. Translational Dementia Research (Bonn) (AG Schneider)
  14. Epigenetics and Systems Medicine in Neurodegenerative Diseases (AG Fischer)
  15. Patient Studies (AG Klockgether)
  16. Molecular biomarkers for predictive diagnostics of neurodegenerative diseases (AG Wiltfang)
  17. Clinical Alzheimer’s Disease Research (AG Jessen)
  18. Vascular Cognitive Impairment & Post-Stroke Dementia (AG Dichgans)
  19. Clinical Neurophysiology and Memory (AG Düzel)
  20. Delcode (Delcode)
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)
  2. 351 - Brain Function (POF4-351) (POF4-351)
  3. 352 - Disease Mechanisms (POF4-352) (POF4-352)
Experiment(s):
  1. Longitudinal Cognitive Impairment and Dementia Study

Appears in the scientific report 2022
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > BN DZNE > BN DZNE-Clinical Research Platform (CRP)
Institute Collections > BN DZNE > BN DZNE-Clinical Research (Bonn)
Institute Collections > BN DZNE > BN DZNE-Patient Studies (Bonn)
Institute Collections > MD DZNE > MD DZNE-Magdeburg common
Document types > Articles > Journal Article
Institute Collections > GÖ DZNE > GÖ DZNE-AG Wiltfang
Institute Collections > BN DZNE > BN DZNE-AG Schneider
Institute Collections > GÖ DZNE > GÖ DZNE-AG Fischer
Institute Collections > ROS DZNE > ROS DZNE-AG Teipel
Institute Collections > TÜ DZNE > TÜ DZNE-AG Gasser
Institute Collections > BN DZNE > BN DZNE-AG Jessen
Institute Collections > MD DZNE > MD DZNE-AG Düzel
Institute Collections > BN DZNE > BN DZNE-AG Wagner
Institute Collections > BN DZNE > BN DZNE-Biomarker
Institute Collections > M DZNE > M DZNE-AG Dichgans
Institute Collections > B DZNE > B DZNE-AG Priller
Institute Collections > MD DZNE > MD DZNE-AG Speck
Institute Collections > M DZNE > M DZNE-AG Simons
Institute Collections > B DZNE > B DZNE-AG Endres
Institute Collections > TÜ DZNE > TÜ DZNE-ICRU
Institute Collections > M DZNE > M DZNE-Delcode
Public records
Publications Database

 Record created 2022-04-06, last modified 2024-08-26


Fulltext:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)